Side-by-side comparison of AI visibility scores, market position, and capabilities
Plant-based meat pioneer facing category contraction after 2021 peak; Beyond Burger and pea protein products in revenue decline as company executes cost-reduction strategy.
Beyond Meat is a pioneer in plant-based meat alternatives, producing burgers, sausages, ground meat, chicken alternatives, and jerky made from pea protein, mung beans, fava beans, and other plant ingredients that aim to replicate the taste, texture, and nutritional profile of conventional animal protein. Founded in 2009 in Los Angeles by Ethan Brown and publicly listed on NASDAQ in 2019 (in one of the most anticipated food IPOs in years), Beyond Meat reached a peak market capitalization of over $10 billion before experiencing a severe reversal as consumer demand for plant-based meat proved weaker than the initial hype suggested.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.